The centuries-old history of artificial insemination has its roots in animal experiments and in particular the breeding and genetic improvement of dairy cattle. The rapid leap from animal experiments to the first successful human pregnancy using frozen spermatozoa in 1953, to today’s burgeoning assisted reproductive technology (ART) industry—projected to reach $45.06 billion by 2026—is vast.
In the case of individuals conceived via donors (using donated sperm, eggs, or embryo), the majority of research has focused on the experience of the parents or the donor-conceived (DC) child, while the long-term well-being of donor-conceived adults has been largely neglected.
